• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MICROVENTION, INC. AZUR-35 DETACHABLE HYDRO; DEVICE VASCULAR FOR PROMOTING EMBOLIZATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MICROVENTION, INC. AZUR-35 DETACHABLE HYDRO; DEVICE VASCULAR FOR PROMOTING EMBOLIZATION Back to Search Results
Model Number 45-452020
Medical Device Problem Code Premature Separation (4045)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 02/12/2025
Type of Reportable Event Malfunction
Event or Problem Description
As reported, the coil detached unexpectedly, without any intervention from the detachment controller, and was repositioned and completed using another classic coil system.Additional information indicated: the coil was left in the kt, it was pushed to the guide place it properly without the security of controlled release.No replacement necessary, it was a single coil before sticking on pelvic varicose veins.
 
Additional Manufacturer Narrative
A search for non-conformances associated with the reported part/lot number combination did not reveal any production-related issues relevant to the complaint that occurred during manufacturing of the device.The device was not returned to the manufacturer for analysis; therefore, the alleged product issue cannot be confirmed.If the device or additional information is received, microvention, inc., will submit a supplemental mdr report.The instructions for use (ifu) identifies premature or difficult coil detachment as potential complications associated with use of the device.
 
Additional Manufacturer Narrative
The investigation of the returned coil system found the pusher returned without the implant attached, but no indications of activation using a detachment controller was observed on the pusher heater coil.The implant was not returned for evaluation.The investigation found the pusher¿s monofilament with a tensile break shape at the tip, which is consistent with the device experiencing force that exceeded the strength of the monofilament causing the implant to separate from the pusher.The catheter used in the procedure was not returned, so the investigation could not determine if it had caused or contributed to the reported complaint.
 
Event or Problem Description
Additional patient demographic information received in sections: a2, a3a, a4.See h11.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AZUR-35 DETACHABLE HYDRO
Common Device Name
DEVICE VASCULAR FOR PROMOTING EMBOLIZATION
Manufacturer (Section D)
MICROVENTION, INC.
35 enterprise
aliso viejo CA 92656
Manufacturer Contact
terrence callahan
35 enterprise
aliso viejo, CA 92656
7142478000
MDR Report Key21579639
Report Number2032493-2025-00214
Device Sequence Number8832583
Product Code KRD
UDI-Device Identifier00810170015038
UDI-Public(01)00810170015038(11)231020(17)280930(10)0000447082
Combination Product (Y/N)N
Initial Reporter CountryUS
PMA/510(K) Number
K122316
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Foreign,Health Professional,User Facility,Company Representative
Initial Reporter Occupation Pharmacist
Type of Report Initial,Followup
Report Date (Section B) 05/02/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model Number45-452020
Device Lot Number0000447082
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 02/26/2025
Supplement Date Received by ManufacturerNot provided
Initial Report FDA Received Date03/11/2025
Supplement Report FDA Received Date05/02/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured10/20/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient Age47 YR
Patient SexFemale
Patient Weight79 KG
-
-